Welcome to the DZIF -

the German Center for Infection Research

Research Areas

DZIF is doing research in nine areas:

Community-Acquired Infections at Mucosal Interfaces

Hepatitis

HIV

Infections of the Immunocompromised Host

Healthcare-Associated Infections

Malaria and Neglected Tropical Diseases

Emerging Infections

Novel Antibiotics

Tuberculosis

News

News and Press Releases:

A cloved hand is taking a swab sample from the tongue in an open mouth
© RioPatuca Images/stock.adobe.com

A single swab is all it takes: Study paves the way for easier tuberculosis detection

European Vaccines Hub Annual Meeting 2026
© Olaf Küffner

European Vaccines Hub for Pandemic Readiness marks one year of progress

The European Vaccines Hub (EVH) for Pandemic Readiness convened its annual consortium meeting at the Old University of the Marburg University, in Marburg, Germany, from May 19 to 21, 2026. The EVH is
Stephan Urban

US Food and Drug Administration (FDA) approves hepatitis drug Hepcludex (bulevirtide)

With the FDA approval of Hepcludex (bulevirtide), a therapy for chronic hepatitis D developed at the Heidelberg Faculty of Medicine at Heidelberg University, Heidelberg University Hospital, and the
Person in protective gear walking along a hallway
© BNITM

Improving the treatment of Lassa fever—first clinical trial with favipiravir shows promising results

Although the infectious disease Lassa fever can be fatal, there is a lack of treatment options with proven efficacy. Researchers at the Bernhard Nocht Institute for Tropical Medicine (BNITM) and the
Filamentous virus particle
© CDC/Frederick A. Murphy

Ebola outbreak in the Democratic Republic of the Congo and Uganda: Current assessment of the epidemic situation

The World Health Organization (WHO) has declared the current Ebola outbreak in the Democratic Republic of the Congo (DR Congo) and Uganda a public health emergency of international concern. The
All news

What is the DZIF? Find out more in our

DZIF movie

More than 700 people work at the DZIF with the common goal of translating basic research into clinical practice. The well-being of the patient is our primary focus. Get more insights in our new DZIF film:

Watch the movie
A GIF animation with clips from the DZIF film.

Always up-to-date

Sign up for our quarterly newsletter and our press releases and stay up to date.

Select mailing lists
CAPTCHA
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.

Follow us on:

The DZIF Media Centre

The DZIF in Videos, Pictures and Print.

Find Media Content

Research in Focus

Hannover - Braunschweig | Heidelberg | München | Tübingen

Transplant Cohort

Medical data and biological samples obtained from transplant patients are collected and managed across Germany with the help of the DZIF Transplant Cohort. The data and samples form the basis of scientific studies which investigate the connections between numerous factors influencing an organ’s susceptibility to infection and organ function. By [...]

Read more
Hamburg - Lübeck - Borstel - Riems

Clinical Tuberculosis Center (ClinTB)

The Clinical Tuberculosis Center provides the expertise and infrastructure for the optimization, prevention, diagnosis, and treatment of tuberculosis (TB) as well as for translating research results into clinical practice. The main objectives of the Clinical Tuberculosis Center include coordinating clinical research activities involving the DZIF TB cohort. This cohort includes [...]

Read more
Tübingen

New strategies for specific eradication of Staphylococcus aureus

In this project, the scientists develop genetically engineered phage lysins and specific bacteriocins for the elimination of hospital germs such as Staphylococcus aureus, they clarify mechanisms of potential resistance mechanisms, and they analyse whether broad-spectrum or specifically acting agents have a more effective and lasting effect on colonization by [...]

Read more
Hannover - Braunschweig

Preclinical development of Amidochelocardins

The challenge of antibiotic drug development today is the discovery and optimisation of novel bioactive compounds that do not show cross-resistances with clinically applied antibiotics, ideally due to a novel mode of action (MoA) which adresses unexploited microbial targets. In the case of chelocardin, this antibiotic substance was identified several [...]

Read more

Our Partner Sites

Location

Hamburg - Lübeck - Borstel - Riems

Research areas
Contact person
Nicole Fischer

Prof. Dr. Nicole Fischer

University Medical Center Hamburg-Eppendorf
Deputy Partner Site Speaker Hamburg-Lübeck-Borstel-Riems
Coordinator Bridging Topic "Diagnostics"
E-Mail Send mail
More about this location
Location

Bonn - Köln

Research areas
Contact person
Prof Achim Hörauf: Coordinator of the consortium "Neglected tropical diseases" at DZIF.

Prof. Dr. Achim Hörauf

University Hospital Bonn
Deputy Partner Site Speaker Bonn-Köln
Deputy Coordinator "Malaria and Neglected Tropical Diseases"
E-Mail Send mail
More about this location
Location

Hannover - Braunschweig

Research areas
Contact person
Silke Hartmann

Dr. Silke Hartmann

Hannover Medical School
Partner Site Manager Hannover-Braunschweig
Project Manager "Community-Acquired Infections at Mucosal Interfaces"
E-Mail Send mail
More about this location
München Tübingen Heidelberg Gießen – Marburg – Langen Bonn – Köln Hannover – Braunschweig Hamburg – Lübeck Borstel – Riems